Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Women treated for gynaecological cancer perceive many difficulties in life on the personal, social, and physical levels. Today they are offered a 3 to 5 year follow-up programme at the hospital where the main purpose is to improve survival. However, the women are very nervous before follow-up visits and although they feel safe about them, they express that their needs of psychosocial care and self-management support are not fulfilled.
The proposed study will test a person-centred intervention tailored the women's needs in a randomised controlled trial. The intervention will be based on the method Guided Self Determination (GSD), which has proved able to realize empowerment in practice in relationships between patients and healthcare professionals. GSD involves systematic use of condition-adjusted worksheets ('reflection sheets'), and advanced professional communication. Using reflection sheets filled out by each woman as the starting point for communication, problem solving will be tailored her personal needs. We expect that the intervention has the potential to support the women in better managing specific complications and difficulties related to concerns about recovery, body perception, fertility and establishment of intimate relations with their partner, all aspects important for the women's quality of life in the follow-up period after cancer diagnosis and treatment. The study will be the first to test GSD in cancer patients.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Autonomy-supportive counselling | Experimental | 2-4 autonomy-supportive conversations with an experienced nurse, educated both theoretically and practically in the method Guided Self-Determination that includes specific "reflection sheets" and use of advanced communication; in addition to standard care. |
|
| Control | No Intervention | Standard of care. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Autonomy supportive counselling | Behavioral |
|
| Measure | Description | Time Frame |
|---|---|---|
| Primary Outcome: Quality of life measured by the scale Quality of life- Cancer Survivors (QOL-CS) | +/- one week for practical reasons | 9 months after randomisation |
| Measure | Description | Time Frame |
|---|---|---|
| Quality of Life measured by the scale Quality of Life Cancer Survivors- (QOL-CS) | +/- one week for practical reasons | 3 months after randomisation |
| Changes in Quality of life in the two groups |
Not provided
Inclusion Criteria:
Exclusion criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Gynaecological Department, Juliane Marie Centret,Copenhagen University Hospital Rigshospitalet | Copenhagen | Copenhagen Ø | 2100 | Denmark |
Not provided
| Label | URL |
|---|---|
| Statistical analysis plan | View source |
| Copenhagen University Hospital, Rigshospitalet has changed to a new web system therefore a new url adress/Statistical analysis plan | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Quality of life at 9 months minus the quality of life at the time of randomisation.
| 9 months |
| Positive and negative impact of cancer measured by Impact of Cancer version 2 (IOCv2) | +/- one week for practical reasons | 3 and 9 months after randomisation |
| Self-esteem measured by Rosenbergs Self Esteem Scale | +/- one week for practical reasons | 3 and 9 months after randomisation |
| Anxiety and depression measured by Hospital Anxiety and Depression Scale (HADS) | Also used as screening instrument baseline. +/- one week for practical reasons | 3 and 9 months from randomisation |
| Autonomy-supportive relationship between patient and health care professionals measured by Health Care Climate Questionnaire (HCCQ) | +/- one week for practical reasons | 3 and 9 months from randomisation |
| Distress measured by Distress Thermometer(DT). | Also used as screening instrument baseline. +/- one week for practical reasons. | 3 and 9 months from randomisation |
| Symptom monitoring and recognition | Womens ability to know what symptoms to monitor and react to in case of recurrence | 3 and 9 months after randomisation (+/- one week for practical reasons) |